128 related articles for article (PubMed ID: 35868516)
1. Phloretin exhibits potential food-drug interactions by inhibiting human UDP-glucuronosyltransferases in vitro.
Chen J; Zhang H; Hu X; Xu M; Su Y; Zhang C; Yue Y; Zhang X; Wang X; Cui W; Zhao Z; Li X
Toxicol In Vitro; 2022 Oct; 84():105447. PubMed ID: 35868516
[TBL] [Abstract][Full Text] [Related]
2. Cabozantinib Carries the Risk of Drug-Drug Interactions
Wang Z; Jiang L; Wang X; Yin H; Wang Z; Lv X; Liu Y
Curr Drug Metab; 2022; 23(11):912-919. PubMed ID: 36306450
[TBL] [Abstract][Full Text] [Related]
3. Piceatannol exhibits potential food-drug interactions through the inhibition of human UDP-glucuronosyltransferase (UGT) in Vitro.
Jiang L; Wang Z; Wang X; Wang S; Wang Z; Liu Y
Toxicol In Vitro; 2020 Sep; 67():104890. PubMed ID: 32446839
[TBL] [Abstract][Full Text] [Related]
4. Drug-drug interaction potentials of tucatinib inhibition of human UDP-glucuronosyltransferases.
Lv X; Wang Z; Wang Z; Yin H; Xia Y; Jiang L; Liu Y
Chem Biol Interact; 2023 Aug; 381():110574. PubMed ID: 37263554
[TBL] [Abstract][Full Text] [Related]
5. Pterostilbene supplements carry the risk of drug interaction via inhibition of UDP-glucuronosyltransferases (UGT) 1A9 enzymes.
Jiang L; Zhang Z; Xia Y; Wang Z; Wang X; Wang S; Wang Z; Liu Y
Toxicol Lett; 2020 Mar; 320():46-51. PubMed ID: 31812603
[TBL] [Abstract][Full Text] [Related]
6. Potential interactions among myricetin and dietary flavonols through the inhibition of human UDP-glucuronosyltransferase in vitro.
Li X; Wang C; Chen J; Hu X; Zhang H; Li Z; Lan B; Zhang W; Su Y; Zhang C
Toxicol Lett; 2022 Apr; 358():40-47. PubMed ID: 35063619
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the inhibition potential of Licochalcone A against human UDP-glucuronosyltransferases.
Xin H; Qi XY; Wu JJ; Wang XX; Li Y; Hong JY; He W; Xu W; Ge GB; Yang L
Food Chem Toxicol; 2016 Apr; 90():112-22. PubMed ID: 26875642
[TBL] [Abstract][Full Text] [Related]
8. Drug-Drug Interaction Potentials of Tyrosine Kinase Inhibitors via Inhibition of UDP-Glucuronosyltransferases.
Zhang N; Liu Y; Jeong H
Sci Rep; 2015 Dec; 5():17778. PubMed ID: 26642944
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of acetaminophen glucuronidation by UDP-glucuronosyltransferases 1A1, 1A6, 1A9 and 2B15. Potential implications in acetaminophen-induced hepatotoxicity.
Mutlib AE; Goosen TC; Bauman JN; Williams JA; Kulkarni S; Kostrubsky S
Chem Res Toxicol; 2006 May; 19(5):701-9. PubMed ID: 16696573
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of aflatoxins on UDP-glucuronosyltransferases (UGTs).
Du Z; Liu ZZ
Toxicol In Vitro; 2023 Aug; 90():105612. PubMed ID: 37164184
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Sweated and Non-Sweated Ethanol Extracts of
Liu J; Shi Y; Wu C; Hong B; Peng D; Yu N; Wang G; Wang L; Chen W
Curr Drug Metab; 2022; 23(6):473-483. PubMed ID: 35585828
[TBL] [Abstract][Full Text] [Related]
12. Everolimus-inhibited multiple isoforms of UDP-glucuronosyltransferases (UGTs).
Du Z; Wang G; Cao YF; Hu CM; Yang K; Liu YZ; Zhang CZ; Zhang WH; Zhu ZT; Sun HZ; Sun XY; Hong M; Fang ZZ
Xenobiotica; 2018 May; 48(5):452-458. PubMed ID: 28548030
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of UDP-Glucuronosyltransferase (UGT) Isoforms by Arctiin and Arctigenin.
Zhang H; Zhao Z; Wang T; Wang Y; Cui X; Zhang H; Fang ZZ
Phytother Res; 2016 Jul; 30(7):1189-96. PubMed ID: 27145339
[TBL] [Abstract][Full Text] [Related]
14. The inhibition of UDP-glucuronosyltransferases (UGTs) by vitamin A.
Liu X; Cao YF; Dong PP; Zhu LL; Zhao Z; Wu X; Fu ZW; Huang CT; Fang ZZ; Sun HZ
Xenobiotica; 2017 May; 47(5):376-381. PubMed ID: 27359323
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human UDP-glucuronosyltransferase enzyme by ripretinib: Implications for drug-drug interactions.
Lv X; Wang Z; Wang Z; Yin H; Xia Y; Jiang L; Liu Y
Toxicol Appl Pharmacol; 2023 May; 466():116490. PubMed ID: 36963523
[TBL] [Abstract][Full Text] [Related]
16. Potential risk of drug-drug interactions of ponatinib via inhibition against human UDP-glucuronosyltransferases.
Ye W; Wang Z; Lv X; Yin H; Jiang L; Wang Z; Liu Y
Toxicol In Vitro; 2023 Oct; 92():105664. PubMed ID: 37597759
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human UDP-glucuronosyltransferase enzyme by Dabrafenib: Implications for drug-drug interactions.
Yin H; Wang Z; Wang X; Lv X; Fan X; Yan M; Jia Y; Jiang L; Cao J; Liu Y
Biomed Chromatogr; 2021 Nov; 35(11):e5205. PubMed ID: 34192355
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of fifteen phthalate esters in human cDNA-expressed UDP-glucuronosyltransferase supersomes.
Cao YF; Du Z; Zhu ZT; Sun HZ; Fu ZW; Yang K; Liu YZ; Hu CM; Dong PP; Gonzalez FJ; Fang ZZ
Chemosphere; 2017 Oct; 185():983-990. PubMed ID: 28753904
[TBL] [Abstract][Full Text] [Related]
19. In vitro inhibition of human UDP-glucuronosyltransferase (UGT) 1A1 by osimertinib, and prediction of in vivo drug-drug interactions.
Wang Z; Wang X; Wang Z; Jia Y; Feng Y; Jiang L; Xia Y; Cao J; Liu Y
Toxicol Lett; 2021 Sep; 348():10-17. PubMed ID: 34044055
[TBL] [Abstract][Full Text] [Related]
20. Screening of non-steroidal anti-inflammatory drugs for inhibitory effects on the activities of six UDP-glucuronosyltransferases (UGT1A1, 1A3, 1A4, 1A6, 1A9 and 2B7) using LC-MS/MS.
Joo J; Kim YW; Wu Z; Shin JH; Lee B; Shon JC; Lee EY; Phuc NM; Liu KH
Biopharm Drug Dispos; 2015 May; 36(4):258-64. PubMed ID: 25522350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
